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Most Neisseria gonorrhoeae isolates are unable to use human hemoglobin as the sole source of iron for growth
(Hgb2), but a minor population is able to do so (Hgb1). This minor population grows luxuriously on
hemoglobin, expresses two outer membrane proteins of 42 kDa (HpuA) and 89 kDa (HpuB), and binds
hemoglobin under iron-stressed conditions. In addition to the previously reported HpuB, we identified and
characterized HpuA, which is encoded by the gene hpuA, located immediately upstream of hpuB. Expression of
both proteins was found to be controlled at the translational level by frameshift mutations in a run of guanine
residues within the hpuA sequence encoding the mature HpuA protein. The “on-phase” hemoglobin-utilizing
variants contained 10 G’s, while the “off-phase” variants contained 9 G’s. Insertional hpuB mutants of FA19
Hgb1 and FA1090 Hgb1 no longer expressed HpuB but still produced HpuA. A polar insertional mutation of
the upstream hpuA gene in FA1090 Hgb1 eliminated production of both HpuA and HpuB, whereas a nonpolar
insertional mutant expressed HpuB only. Insertional mutagenesis of either hpuA or hpuB or both substantially
decreased the hemoglobin binding ability of the FA1090 Hgb1 variant and prevented growth on hemoglobin
plates. Therefore, both HpuA and HpuB were required for the utilization of hemoglobin for growth.
Mammalian hosts use iron-binding proteins and iron-se-
questering compounds to maintain free iron at a level that is
too low for the growth of invading bacterial pathogens (52).
Several pathogenic organisms have developed specific mecha-
nisms for iron acquisition which are induced under conditions
of iron limitation. The genital mucosal pathogen Neisseria gon-
orrhoeae is known to use iron from lactoferrin and transferrin
for growth (37, 38). The ability to use lactoferrin and trans-
ferrin is due to specific receptors (reviewed in reference 11).
Gonococci also are able to utilize heme and certain heme-
containing proteins as iron sources (15, 38). Two heme-binding
proteins (99 and 44 kDa) have been isolated from the total
membranes of gonococcal clinical isolates grown under iron-
limited conditions (26, 29). Nevertheless, the mechanism of
iron uptake from heme-containing proteins is unclear.
Mickelsen and Sparling (38) showed that 18 of 29 gonococ-
cal strains studied were capable of using hemoglobin for
growth. Lee and Hill (28) detected hemoglobin binding activity
from Neisseria meningitidis grown under iron-limited condi-
tions. More recently, two different meningococcal hemoglobin
receptors have been described at the molecular level. Stojiljk-
ovic et al. (49, 50) cloned a gene encoding an iron-regulated
outer membrane protein, HmbR, which has amino acid simi-
larity with the family of TonB-dependent membrane receptors.
Lewis and Dyer (30) and Lewis et al. (31) described hpuAB, the
hemoglobin-haptoglobin utilization operon of N. meningitidis,
and suggested that HpuA and HpuB constitute a two-compo-
nent receptor analogous to the bipartite transferrin receptor
TbpB-TbpA (formerly named Tbp2-Tbp1) (reviewed in refer-
ence 11). Predicted amino acid sequences of N. meningitidis
HpuA and HpuB indicate that, like TbpB and TbpA, HpuB
belongs to the TonB-dependent family of high-affinity trans-
port proteins and HpuA is probably a lipoprotein (31).
We previously reported that all tested gonococcal strains can
use hemoglobin as a sole source of iron for growth by switching
from a non-hemoglobin-utilizing phenotype (Hgb2) to a he-
moglobin-utilizing phenotype (Hgb1) in vitro. In order to dis-
tinguish these two phenotypes of the same strain, we classified
gonococci able to grow on hemoglobin-Desferal plates as
Hgb1 variants and those unable to grow on hemoglobin-Des-
feral plates as Hgb2 variants (8). The ability to use hemoglobin
for growth appears to be a phase-varying phenomenon, be-
cause Hgb1 variants arise from Hgb2 parents at a frequency of
about 1 3 1024 to 2 3 1023 (8). In this communication, we
describe the mechanism underlying the phase variation of he-
moglobin utilization and the characteristics of a 42-kDa HpuA
protein encoded by the gonococcal hpuA gene. We also previ-
ously reported that insertional mutants that no longer ex-
pressed the 89-kDa HpuB protein cannot utilize hemoglobin
to support growth but still grow on heme (8). Now we report on
the requirement for HpuA in the utilization of hemoglobin for
growth by N. gonorrhoeae.
MATERIALS AND METHODS
Bacterial strains and growth conditions. N. gonorrhoeae strains used are listed
in Table 1. Both Hgb1 and Hgb2 variants of FA1090 and FA19 were used.
Growth conditions were the same as those described by Chen et al. (8), with the
exception that the iron chelator Desferal (deferoxamine mesylate; CIBA Phar-
maceutical Co.) was used at a 100 mM final concentration for FA1090 and
insertional mutants of FA1090. The abilities of FA1090 Hgb2 and Hgb1 variants
and their hpuA and/or hpuB insertional mutants to grow on heme were tested on
modified gonococcal medium base (GCB) agar plates (8) containing bovine
hemin chloride (Sigma) at 5 mg/liter and Desferal at 100 mM. Antibiotic selec-
tion in gonococci employed erythromycin at 1 mg/liter for mini-Tn3erm inser-
tions (30), spectinomycin at 100 mg/liter for the V interposon insertions (44), and
kanamycin at 60 mg/liter for the aphA-3 cassette insertions (35).
Sequencing the gonococcal hpuA gene. Double-stranded PCR products, puri-
fied with a Geneclean II kit (Bio 101, Inc.), were sequenced directly. Chromo-
somal DNAs of FA1090 Hgb1 and FA1090 Hgb2 were used as templates for
PCRs. Initially, the putative open reading frame of FA1090 hpuA was identified
from the database of the Gonococcal Genome Sequencing Project (Advanced
Center for Genome Technology, University of Oklahoma) by searching for the
coding sequence of the N terminus of FA1090 HpuB (8). The 19-mer upstream
PCR primer (hpu.01, GCAGGCACGTCCGATTTCC) was designed based on
the sequence 108 bp upstream of the ATG codon of the putative hpuA open
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reading frame (Fig. 1). A 20-mer downstream primer (hpu.14, ACAAAACCC
AAAAACTCGGAC) was designed, based on the N-terminal amino acid se-
quence of HpuB, to generate PCR DNA fragments covering the entire hpuA
gene (Fig. 1). Two PCRs were carried out for each variant. One used purified
chromosomal DNA, and the other used boiled cells, as the template. PCR
products were pooled for sequencing. Both strands of the PCR-generated hpuA
DNA were sequenced by using hpu.01, hpu.14, and four additional internal
primers.
In order to verify that hemoglobin-utilizing and non-hemoglobin-utilizing vari-
ants of N. gonorrhoeae contained different numbers of guanine (G) residues in
the poly(G) tract of hpuA, guanine residues were enumerated from sequences of
PCR products covering the poly(G) tract but not the entire hpuA. Two sets of
templates were prepared from each variant of FA19 and FA1090. One was the
purified chromosomal DNA, and the other was boiled cells. A 19-mer down-
stream primer (hpu.02, CATCTTCAAAACACCCGGC) was designed based on
the sequence 247 bp downstream from the end of the poly(G) tract (314 bp from
the initial ATG codon shown in Fig. 1). PCRs using the primer pair hpu.01 and
hpu.02 were expected to generate DNA fragments of 439 bp from Hgb2 variants
and of 440 bp from Hgb1 variants. Sequencing of PCR-generated partial FA1090
hpuA fragments was carried out on both strands with primers hpu.01 and hpu.02.
Sequencing of PCR-generated partial FA19 hpuA fragments was carried out on
single strands only.
Oligonucleotides were synthesized at the Lineberger Comprehensive Cancer
Center DNA Synthesis Facility of the University of North Carolina—Chapel
Hill. DNA sequencing was carried out at the Automated DNA Sequencing
Facility of the University of North Carolina—Chapel Hill with an Applied Bio-
systems model 373 DNA sequencer by use of the Tag DyeDeoxy Terminator
Cycle Sequencing kit (Applied Biosystems).
Cloning of the hpuA gene. Routine molecular cloning techniques as described
by Sambrook et al. (47) were used. Plasmid DNAs were isolated by either the
Wizard Minipreps DNA purification system (Promega) or the Qiagen DNA
purification system. Chromosomal DNA from N. gonorrhoeae was purified by the
method of Stern et al. (48). The 1,360-bp PCR DNA made from the FA1090
Hgb2 template and the 1,361-bp PCR DNA made from the FA1090 Hgb1
template were inserted into the pCRII vector by using the TA cloning kit
(Invitrogen) to yield pUNCH258 and pUNCH259, respectively.
Insertional mutagenesis of the hpuA gene. (i) Construction of polar hpuA
insertional mutants. In order to avoid potential variations in the poly(G) region
during experimental manipulation of hpuA, insertional mutagenesis of hpuA was
carried out within a NarI-XbaI fragment isolated from pUNCH258 (Fig. 1). The
NarI site was located 108 bp downstream of the poly(G) tract, and the XbaI site
was present in the polylinker of pCRII. The NarI-XbaI fragment was subcloned
into the pBluescript II KS1 phagemid (Stratagene) digested with XbaI-AccI to
yield pUNCH260. In order to avoid blocking of PpuMI digestion by Dcm meth-
ylase activity, pUNCH260 was moved from Escherichia coli DH5aMCR (Be-
thesda Research Laboratories) to GM2163 (New England Biolabs). The 2-kb V
interposon fragment isolated from SmaI-cut pHP45V (44) was ligated with
pUNCH260, digested with PpuMI, and filled in with the Klenow fragment of
DNA polymerase I (Fig. 1) to yield pUNCH268. pUNCH268, containing an V
insert in the hpuA fragment, was then transformed into FA1090 Hgb2 and
FA1090 Hgb1 to generate FA6981 and FA6982, respectively. Transformant
colonies were screened for resistance to spectinomycin at 100 mg/liter and the
inability to grow on hemoglobin-Desferal plates.
(ii) Construction of a nonpolar hpuA insertional mutant. A mutagenic cassette
designed to be inserted into a gene of an operon without affecting transcription
of downstream genes (35) was adopted for our construction of a nonpolar hpuA
mutant. The 800-bp aphA-3 insert cassette was isolated from pUC18K by SmaI
digestion (35) and was ligated to PpuMI-digested pUNCH260 to generate
pUNCH271. pUNCH271 was then transformed into FA1090 Hgb1 to create
FA6983. Transformant colonies were screened for resistance to kanamycin at 60
mg/liter and the inability to grow on hemoglobin-Desferal plates.
Enumeration of G residues. The cloned hpuA gene in pUNCH258 and
pUNCH259 was sequenced with M13 reverse primer (Invitrogen). The guanine
residues in hpuA from FA6981, FA6982, and FA6983 were enumerated from
PCR products generated by the primer pair hpu.01 and hpu.02 in order to
confirm that gonococcal transformants containing the mutagenized fragment of
hpuA kept the same number of guanine residues in the poly(G) tract as was
present in the parents. Primer hpu.01 was used in sequencing those partial hpuA
fragments from mutants.
DNA hybridization. Southern blots were utilized to confirm that allelic ex-
change occurred as expected. Chromosomal DNAs of FA1090 Hgb2, FA1090
Hgb1, and hpuA or hpuB insertional mutants of FA1090 Hgb1 (FA6982,
FA6983, and FA6929) were digested with ClaI and separated on 0.7% agarose
gels. Gels were transferred bidirectionally to Magnagraph nylon membranes
(Micron Separations). Blots were probed, as described in Results, with random-
primed digoxigenin-dUTP-labeled DNA and were developed according to the
Genius labeling and detection instructions (Boehringer Mannheim Biochemi-
cals).
Peptide synthesis and immunization. A 20-mer peptide was designed based on
the predicted strong antigenicity of the last 17 amino acids of the C terminus of
HpuA (CGG-EKKLDDTSQDTNHLTKQ). Another peptide (CGG-ADPAPQ
SAQTLN) was designed previously based on the N-terminal amino acid se-
quence of HpuB (8). Peptide synthesis was performed at the University of North
Carolina Program in Molecular Biology and Biotechnology MicroProtein Chem-
istry Facility with a multiple peptide synthesizer (Rainin Symphony). Peptide
synthesis and immunization followed the procedures described by Elkins (16)
and Chen et al. (8).
Affinity purification of antibodies raised against the N-terminal peptide of
HpuB and the C-terminal peptide of HpuA. Postimmune antipeptide sera for
HpuB (8) and HpuA were each affinity purified to eliminate reactivity to antigens
other than HpuA and HpuB. A modification of a previously published method as
reported by Elkins et al. (17) was used for the affinity purification of antipeptide
antibodies on immobilized peptide coupled on thiopropyl-agarose columns (Sig-
ma) (42).
Preparations of whole-cell dot blots and outer membranes from gonococci
grown under iron-replete and iron-stressed conditions. Gonococci were grown
in iron-sufficient and iron-limited media. Gonococcal medium broth containing
Kellogg’s supplement I was inoculated from overnight plate-grown gonococcal
cultures (Hgb2 on GCB plates and Hgb1 on hemoglobin-Desferal plates). After
FIG. 1. Descriptive map of FA1090 hpuA. Numbers indicate positions of first
nucleotides. The open reading frames (ORFs) for hpuA and hpuB start at
nucleotide positions 01 and 1,110, respectively. Beginning from position 43 is a
consensus coding sequence for a type-II signal peptidase cleavage site, LAAC. A
run of multiple guanine residues was located in hpuA, starting from position 58.
The asterisk indicates a stop codon. A 1,130-bp fragment was isolated between
the NarI site in hpuA and an XbaI site in the vector for mutagenesis. The PpuMI
site was the insertion site for making various mutants. The primer pair, hpu.01
and hpu.14, was used in PCRs for the cloning of hpuA. The other primer pair,
hpu.01 and hpu.02, was used to generate PCR products for enumerating guanine
residues in the poly(G) tract.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Genotype Source orreference
Gonococcal strains
FA1090 Wild type; Hgb1 and Hgb2 variants 41
FA19 Wild type; Hgb1 and Hgb2 variants 38
FA6929 FA1090 Hgb1; hpuB::mTn3erm 8
FA6930 FA19 Hgb1; hpuB::mTn3erm 8
FA6981 FA1090 Hgb2; hpuA::V This work
FA6982 FA1090 Hgb1; hpuA::V This work
FA6983 FA1090 Hgb1; hpuA::aphA-3 This work
Plasmids
pSM85k 850-bp ApoI fragment of hpu in pHS8 30
pSM85kE pSM85k::mTn3erm; source for
hpuB::mTn3erm
30
pHP45V Source for V interposon (Smr) 44
pUC18K 850-bp aphA-3 cassette in pUC18 (Kmr) 35
pUNCH258 hpuA clone from FA1090 Hgb2 in
pCRII
This work
pUNCH259 hpuA clone from FA1090 Hgb1 in
pCRII
This work
pUNCH260 NarI-XbaI segment from pUNCH 258;
hpuA fragment with no poly(G) tract
This work
pUNCH268 PpuMI-cut pUNCH260 with SmaI-cut
V in pBluescript II KS1
This work
pUNCH271 PpuMI-cut pUNCH260 with SmaI cut-
aphA-3 in pBluescript II KS1
This work
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one mass doubling, cultures were split. Desferal was added to a 100 mM con-
centration to induce iron starvation in one flask, whereas supplement II (ferric
nitrate at 12 mM) was added to the other flask. After 4 h of growth with either
the chelator or the iron supplement, cells were harvested by centrifugation. The
density of harvested cells was adjusted to an optical density of 0.2 at 600 nm
(approximately 2 3 108 CFU/ml) with phosphate-buffered saline. Dot blots were
prepared from wells loaded with 100 ml of the adjusted cell suspensions. Total
membranes and outer membranes were prepared as previously described (16).
The protein content was determined by a bicinchoninic acid assay (Pierce).
Purification of hemoglobin-binding proteins from total membranes. Purifica-
tion of hemoglobin-binding proteins used bovine hemoglobin-agarose (chroma-
tography specialty resin) supplied by Sigma. Purification with solid-phase hemo-
globin-agarose followed a procedure described by Elkins (16). Hemoglobin-
binding proteins were eluted in Laemmli sample buffer for analytical sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting (immunoblotting).
Whole-cell dot blot hemoglobin binding assay. FA1090 Hgb1, FA6929, and
hpuA insertional mutants of FA1090 Hgb1 (FA6982 and FA6983) were exam-
ined for their ability to bind hemoglobin in a whole-cell dot blot assay. Human
hemoglobin was biotinylated with N-hydroxysuccinimide–SS–Biotin (21331D;
Pierce) according to the manufacturer’s instructions at a molar ratio of 23:1 at
4°C for 2 h. The unbound biotin was removed by dialysis overnight in phosphate-
buffered saline at 4°C. The binding was detected by a colorimetric procedure
using alkaline phosphatase-conjugated streptavidin (Pierce) as the secondary
reagent.
Western blot analysis of membrane proteins. SDS-PAGE and Western blot-
ting of total membrane proteins, outer membrane proteins, and hemoglobin-
binding proteins purified from total membranes were performed as described by
Harlow and Lane (20). One nitrocellulose membrane each was prepared for
Western blotting of total membrane, outer membrane, and hemoglobin-binding
proteins. These membranes were cut into upper and lower panels along a line
drawn between 55 and 60 kDa. The upper panels were probed with affinity-
purified serum raised against the N-terminal peptide of HpuB (8), and the lower
panels were probed with affinity-purified serum raised against the C-terminal
peptide of HpuA.
RESULTS
Gonococcal hpuA gene. We obtained the sequence of hpuA
from both FA1090 Hgb2 and FA1090 Hgb1 by sequencing
PCR products of the primer pair hpu.01 and hpu.14 directly.
Data containing DNA sequence of FA1090 hpuA have been
released incrementally by the N. gonorrhoeae Genome Se-
quencing Project. The sequence identical to our FA1090 Hgb2
hpuA sequence was released as part of the February 1997
update. Since the sequence of the FA1090 hpuAB operon is
now readily available from the database of the project (the
University of Okalahoma’s Advanced Center for Genome
Technology at http://www.dna1.chem.uoknor.edu) and from
GenBank (accession no. AF031495), the hpuA sequence is not
listed in detail in this communication.
FA1090 hpuA was located immediately upstream from
hpuB, and there was no obvious promoter sequence in the 27
nucleotides that separate hpuA and hpuB. In the hemoglobin-
utilizing variant, the hpuA gene had an open reading frame of
1,079 bp, 56 bp longer than that in the hemoglobin-haptoglo-
bin-utilizing N. meningitidis strain DNM2 (31) (GenBank ac-
cession no. U73112). The putative Fur box in the promoter
region of FA1090 hpuA was identical to that reported for
DNM2. Forty-three base pairs downstream from the ATG
codon was the beginning of a consensus sequence for a type-II
signal peptidase cleavage site, LAAC (21) (Fig. 1). Processing
of the gonococcal HpuA at the LAAC site would produce a
mature peptide of 343 amino acids at a molecular size of 36
kDa. The isoelectric point of unmodified mature peptide was
predicted to be 6.77. The putative HpuA of FA1090 Hgb1 had
an unusual amino acid composition, containing 12.2% serine
and 11.9% glycine. There was 84.2% similarity and 82.0%
identity to the HpuA of DNM2.
One codon after the coding sequence for LAAC was a run of
G residues, starting at nucleotide 58 of hpuA (Fig. 1). Direct
sequencing of hpuA PCR products revealed that the FA1090
variant unable to utilize hemoglobin for growth contained only
9 G’s in the poly(G) tract, while the hemoglobin-utilizing vari-
ant of FA1090 contained 10 G’s. Identical results were ob-
tained from each of the four independent PCRs for both the
Hgb2 variant and the Hgb1 variant. PCR products from FA19
Hgb2 and FA19 Hgb1, two reactions each, also contained 9
G’s for the nonhemoglobin-utilizing variant and 10 G’s for the
hemoglobin-utilizing variant. Since the number of G’s in both
strains was consistent for the respective variants, the difference
in numbers was variant specific and not the result of PCR
error. Deletion of 1 G from the 10-G poly(G) tract resulted in
a frame shift in the coding sequence for HpuA and led to an
immediate stop codon (Fig. 1). Thus, changes in the expression
states of hpuA involved an altered reading frame register and
resulted in switches between the “on phase” and the “off
phase” of hemoglobin utilization.
PCR clones and insertional mutants of hpuA. Curiously,
pUNCH258 and pUNCH259, which were plasmids containing
cloned hpuA from FA1090 Hgb2 and FA1090 Hgb1, respec-
tively, both contained 9 G’s in the poly(G) tract. It seems that
reversion had occurred in the E. coli transformation of
pUNCH259 and that the selection was skewed to clones con-
taining 9 G’s. Insertional mutagenesis of FA1090 Hgb1 re-
sulted in hpuB mutant FA6929 (8) and hpuA mutants FA6982
and FA6983. All three mutants contained 10 G’s in the poly(G)
tract, whereas the hpuA insertional mutant of FA1090 Hgb2,
FA6981, contained 9 G’s. Thus, gonococcal transformation
with a fragment of hpuA containing either the V interposon or
the aphA-3 cassette did not alter the poly(G) region. Changes
in hemoglobin utilization phenotypes of these transformants
reflected changes that resulted from insertional inactivation of
the hpuA and/or the hpuB alleles.
Southern blot analysis of hpuA insertional mutants. In or-
der to confirm that each mutant had the appropriate insertion,
Southern blotting was performed with three separate DNA
probes. One was an 850-bp hpuB fragment of the EcoRI digest
of the plasmid pSM85k (30). The other two were the DNA
fragments of SmaI-cut V interposon (2,082 bp) and SmaI-cut
aphA-3 cassette (787 bp). When chromosomal DNA from ei-
ther FA1090 Hgb2 or FA1090 Hgb1 was digested with ClaI,
the hpuB probe hybridized with a DNA fragment of roughly 8
kb. In FA6929, FA6982, or FA6983, the same probe hybridized
with fragments of approximately 9 to 10 kb. Due to the large
sizes of ClaI-digested fragments, exact sizes of labeled frag-
ments were hard to estimate; nevertheless, sizes of fragments
from the mutants were appropriately larger than the size of the
fragment from the parent (Fig. 2, upper panel). The V probe
hybridized with FA6982 DNA only (Fig. 2A, lower panel), and
the aphA-3 probe hybridized with FA6983 DNA only (Fig. 2B,
lower panel), at the appropriate size positions as predicted.
Localization of the HpuA protein. Expression of both HpuA
and HpuB was iron regulated. While HpuB could be detected
in stained gels of whole-cell lysates, total membrane proteins,
outer membrane proteins, or hemoglobin-binding proteins (8),
HpuA was not readily visible in the Coomassie-stained gels,
the silver-stained (51) gels, or autoradiographs of iodinated
membrane protein gels (data not shown). However, Western
blotting with affinity-purified antibody raised against the C-
terminal peptide of HpuA revealed an iron stress-induced 42-
kDa band in whole cells (data not shown) and membrane
preparations. This band appeared along with the 89-kDa
HpuB in iron-stressed FA1090 Hgb1 (Fig. 3A and B, lanes 2)
and FA19 Hgb1 (data not shown) but was absent in the hpuA
insertional mutants FA6982 and FA6983 (Fig. 3A and B, lanes
6 and 8). The HpuA of hemoglobin-utilizing variants could be
affinity purified from total membrane proteins with immobi-
lized hemoglobin (Fig. 3C, lane 2).
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Expression of HpuA and HpuB in mutants. Since we were
unable to identify any consensus promoter sequence for hpuB,
it was expected that insertional mutation of the upstream hpuA
with the V interposon would prevent expression of both HpuA
and HpuB. On the other hand, since the aphA-3 gene is pre-
ceded by translation stop codons in all three reading frames
and is followed by a consensus ribosome binding site and a
start codon (35), it was expected that successful insertion of the
aphA-3 cassette in hpuA would prevent expression of HpuA
but not of HpuB.
HpuA was present in the total membrane proteins prepared
from the iron-stressed hpuB mutant FA6929 (Fig. 3A, lane 4).
However, when HpuB was absent, HpuA could no longer be
detected in either the outer membrane protein blot or the
hemoglobin-binding protein blot (Fig. 3B and C, lanes 4). The
polar insertional hpuA mutant, FA6982, showed neither HpuA
nor HpuB in all three blots (Fig. 3, lanes 6). The nonpolar
insertional hpuA mutant, FA6983, did not produce HpuA but
did produce HpuB, as expected (Fig. 3A and B, lanes 8). The
amount of HpuB produced in the nonpolar hpuA mutant might
have been reduced, compared to that produced by parent
strain, but precise quantification of expression levels was not
attempted. The hemoglobin binding ability of HpuB from
FA6983 apparently was not affected by the absence of HpuA
(Fig. 3C, lane 8).
Hemoglobin binding and utilization of hpuA insertional mu-
tants. Iron-stressed, hemoglobin-utilizing FA1090 Hgb1
bound biotinylated human hemoglobin in a whole-cell dot blot
assay (Fig. 4). The binding was inhibited by excess unlabeled
hemoglobin but not by excess hemin at a molar ratio of 100:1
(data not shown). The hpuB insertional mutant, FA6929, and
the polar and nonpolar hpuA insertional mutants, FA6982 and
FA6983, all demonstrated impaired binding of biotinylated
hemoglobin (Fig. 4). None of the hpuA or hpuB mutants of
FA1090 Hgb1 (FA6929 [HpuA1 HpuB2], FA6982 [HpuA2
HpuB2], or FA6983 [HpuA2 HpuB1]) was able to grow on
modified GCB plates using human hemoglobin as the sole iron
source (Fig. 5). Nevertheless, all three mutants and both
FA1090 Hgb2 and FA1090 Hgb1 grew well on modified GCB
plates containing hemin (data not shown).
FIG. 2. Southern blot analysis of hpuA and hpuB insertional mutants. Chro-
mosomal DNAs from FA1090 parent and mutant strains were digested with ClaI
and transferred bidirectionally to prepare two blots per gel. Hgb2 was the
non-hemoglobin-utilizing variant, while Hgb1 was the hemoglobin-utilizing vari-
ant and the recipient for insertional mutation. (A) Blots of DNA fragments from
FA6982, a polar insertional hpuA mutant, were probed with an hpuB fragment
(upper panel) and an V fragment (lower panel). (B) Blots of DNA fragments
from FA6929, an hpuB mutant, and FA6983, a nonpolar hpuA mutant, were
probed with an hpuB fragment (upper panel) and an aphA-3 fragment (lower
panel).
FIG. 3. Detection of HpuA and HpuB among the total membrane proteins
(A), the outer membrane proteins (B), and the hemoglobin-binding proteins (C)
prepared from the hpuA and/or hpuB mutants of FA1090 Hgb1 grown under
iron-replete (Fe1) or iron-stressed (Fe2) conditions. FA6929 is an hpuB inser-
tional mutant, and FA6982 and FA6983 are polar and nonpolar hpuA insertional
mutants, respectively. Western blots of total membrane proteins, outer mem-
brane proteins, and hemoglobin-binding affinity-purified proteins were cut into
two panels each, one probed with affinity-purified anti-HpuB serum (upper
panels) and the other probed with affinity-purified anti-HpuA serum (lower
panels).
FIG. 4. Dot blot assay showing binding of biotinylated human hemoglobin to
iron-replete (Fe1) and iron-stressed (Fe2) whole cells. FA1090 Hgb1 is the
parent strain. FA6929 is an hpuB insertional mutant, and FA6982 and FA6983
are polar and nonpolar hpuA insertional mutants, respectively.
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DISCUSSION
In order to examine the mechanism underlying the phase
variation of hemoglobin utilization by N. gonorrhoeae, we stud-
ied the expression and function of a 42-kDa outer membrane
protein, HpuA, identified in the hemoglobin-utilizing variants
of both FA19 and FA1090 grown under iron-stressed condi-
tions. While hpuA was located immediately upstream from
hpuB, the gene encoding the previously reported 89-kDa he-
moglobin-binding outer membrane protein (8), we were un-
able to identify any consensus promoter sequence that might
direct the transcription of hpuB within the short DNA frag-
ment between the stop codon of hpuA and the start codon of
hpuB. Polar insertional mutation of hpuA prevented produc-
tion of both HpuA and HpuB. Thus, it is most likely that, in N.
gonorrhoeae, hpuA and hpuB are comprised in a two-compo-
nent operon similar to that in N. meningitidis (31).
Variation in the expression of gonococcal HpuA and HpuB
was associated with variation in the length of a run of G
residues at the 59 end of hpuA, located within the sequence
encoding the N-terminal amino acids for mature protein. The
hemoglobin-utilizing variants contained 10 G’s, whereas the
non-hemoglobin-utilizing variants contained 9 G’s (Fig. 1).
When hpuA had only 9 G’s, a stop codon occurred immediately
at the end of the poly(G) tract. In Hgb1 variants, the 10-G
poly(G) tract enabled a change of the translational reading
frame and thus the expression of HpuA and HpuB. This ap-
parently explains the high frequency (1 3 1024 to 2 3 1023) of
spontaneous Hgb2-to-Hgb1 variation observed in all tested
gonococcal strains (8). Other gonococcal phase-varying sys-
tems include Pil (19, 36), PilC (25), Opa (33, 48), and lipooli-
gosaccharide (2). The mechanism for phase variation of HpuA
and HpuB is similar to that for Opa, PilC, and lipooligosac-
charide in that each apparently uses slipped-strand mispairing
to alter the length of a short DNA repeat, which affects trans-
lational frame and therefore expression (13, 18, 25, 39, 40).
Although we have been unable to develop a protocol to
detect the on-phase-to-off-phase switch of hemoglobin utiliza-
tion, it is likely that the postulated on-to-off switch also occurs
at a relatively high frequency. It is unclear what advantage
might be gained by phase variation and iron repression of
hemoglobin-binding protein expression. We speculate, how-
ever, that phase variation of a hemoglobin-binding protein in
gonococci would enable efficient utilization of menstrual he-
moglobin. Recently, two genes encoding hemoglobin-binding
proteins of Haemophilus influenzae (HgpA and HgpB) have
been cloned (23, 24, 45). Regions of CCAA nucleotide-repeat-
ing units immediately following the putative leader cleavage
site were identified in both hgpA and hgpB. It has been postu-
lated that alteration of the reading frame across the CCAA
region of hgpA or hgpB by strand slippage would lead to pro-
duction of either protein (23). Thus, the heme-regulated ex-
pression of H. influenzae hemoglobin-binding proteins might
very well be another example of phase variation of hemoglo-
bin-binding proteins.
The gonococcal hpuA gene encodes a consensus signal pep-
tidase II cleavage site (21), suggesting that HpuA is lipid mod-
ified. The difference between the observed molecular mass (42
kDa) and the calculated molecular mass (36 kDa) is consistent
with lipid modification of HpuA. The nonintegral membrane
protein characteristics of HpuA were demonstrated in mem-
brane preparations of the HpuA1 HpuB2 mutant FA6929. In
the absence of the integral outer membrane protein HpuB,
HpuA could not be detected among Sarkosyl-resistant outer
membrane proteins (Fig. 3B) or total membrane proteins sub-
jected to hemoglobin-agarose purification (Fig. 3C). On the
other hand, the absence of HpuA had no obvious effect on the
hemoglobin binding ability of HpuB (Fig. 3C). It is possible
that the apparently decreased binding of FA6983 cells to bio-
tinylated hemoglobin (Fig. 4) was due to decreased production
of HpuB instead of impaired hemoglobin binding by HpuB
(Fig. 3C).
We could not detect hemoglobin binding by HpuA alone in
cell-free systems, but HpuA must play a critical role in the
utilization of hemoglobin for growth. FA6983, the mutant
which expressed HpuB but not HpuA, bound hemoglobin in
affinity purification (Fig. 3C) but was unable to grow on media
where hemoglobin was the sole source of iron (Fig. 5). Thus,
HpuA and HpuB, while showing differences in their abilities to
bind hemoglobin, were both required for hemoglobin utiliza-
tion by gonococci.
Lee (26) reported isolation of two hemin-binding proteins
(HmBPs) by affinity purification from gonococci grown under
iron-limited conditions. These two HmBPs have observed mo-
lecular masses of 44 and 97 kDa, very close to the 42 and 89
kDa of HpuA and HpuB. HmBPs bound to hemin-agarose,
and the binding was competitively inhibited by hemoglobin.
Growth on hemoglobin was inhibited by a monoclonal anti-
body directed against the 97-kDa HmBP (26, 29). These results
suggest that HmBPs might be identical to HpuA and HpuB.
However, our results showed that neither HpuA nor HpuB was
required for growth on hemin plates, and in whole-cell dot blot
assays, hemoglobin binding by FA1090 Hgb1 was not affected
by excess hemin. These are not the results that would be
expected if HpuA and HpuB were identical to the HmBPs. In
the current absence of sequence data for the HmBPs, and of
specific mutants of the HmBPs, we cannot be certain that
HpuA and HpuB are different from the HmBPs.
Gonococci possess multiple specific systems to acquire iron
from different sources: transferrin and lactoferrin (4, 5, 11, 34),
aerobactin (54), enterobactin (46), hemoglobin (38), and, un-
doubtedly, heme (14, 15, 27). This presumably reflects the
differences in available iron at different body sites and under
different physiological conditions (53). Acquisition of iron
from transferrin, lactoferrin, and hemoglobin may involve a
bipartite receptor system. The operon, tbpBA, encoding the
outer membrane lipoprotein, TbpB, and the TonB-dependent
outer membrane transferrin receptor, TbpA, has been well
studied (1, 10, 11). It is also known that there is a gene for a
lipoprotein homologous to tbpB in meningococci immediately
upstream of lbpA, which encodes the TonB-dependent lacto-
ferrin receptor LbpA (6, 7, 32, 43). Recently, a similar lipopro-
FIG. 5. Growth phenotypes on GCB plate (A) and hemoglobin-Desferal
plate (B). FA1090 Hgb2 is the non-hemoglobin-utilizing variant, and FA1090
Hgb1 is the hemoglobin-utilizing variant. FA6929 is an hpuB insertional mutant,
and FA6982 and FA6983 are polar and nonpolar hpuA insertional mutants of
FA1090 Hgb1, respectively.
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tein gene has been found in N. gonorrhoeae, immediately up-
stream of lbpA (3).
The HpuA-HpuB receptor system for utilization of hemo-
globin in N. gonorrhoeae is similar in several respects to that of
TbpB-TbpA. Gonococcal TbpB, a lipid-modified protein,
binds to transferrin in affinity purification but cannot be affinity
purified from a TbpA2 mutant in the presence of the detergent
Sarkosyl (9). HpuA, the lipoprotein analogous to TbpB, was
not Sarkosyl resistant and could be affinity purified only in the
presence of HpuB, the integral outer membrane protein anal-
ogous to TbpA. This could reflect a physical association be-
tween HpuA and HpuB, such as has been proposed for TbpB
and TbpA (12). In N. gonorrhoeae, a TbpB2 mutant shows
reduced binding of transferrin but exhibits growth on trans-
ferrin plates; a TbpA2 mutant binds less transferrin and does
not grow on transferrin plates (1). In these respects, the gono-
coccal TbpB-TbpA system does not correspond to what we
have described for HpuA and HpuB; however, in N. meningi-
tidis, both TbpB2 and TbpA2 mutants are unable to grow on
transferrin-bound iron (22), analogous to the results for the
gonococcal HpuA-HpuB system.
The importance of both HpuA and HpuB in gonococcal
hemoglobin utilization has been demonstrated, but many ques-
tions remain to be answered concerning the exact function and
location of HpuA and HpuB. A better understanding of how
they interact to facilitate iron uptake from hemoglobin will be
the aim of future work.
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